CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes

Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Laisuan, Wannada, Wongsa, Chamard, Chiewchalermsri, Chirawat, Thongngarm, Torpong, Rerkpattanapipat, Ticha, Iamrahong, Pansa, Ruangwattanachok, Chulapha, Nanthapisal, Sira, Sompornrattanaphan, Mongkhon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504472/
https://www.ncbi.nlm.nih.gov/pubmed/34675550
http://dx.doi.org/10.2147/JAA.S333098
_version_ 1784581329902370816
author Laisuan, Wannada
Wongsa, Chamard
Chiewchalermsri, Chirawat
Thongngarm, Torpong
Rerkpattanapipat, Ticha
Iamrahong, Pansa
Ruangwattanachok, Chulapha
Nanthapisal, Sira
Sompornrattanaphan, Mongkhon
author_facet Laisuan, Wannada
Wongsa, Chamard
Chiewchalermsri, Chirawat
Thongngarm, Torpong
Rerkpattanapipat, Ticha
Iamrahong, Pansa
Ruangwattanachok, Chulapha
Nanthapisal, Sira
Sompornrattanaphan, Mongkhon
author_sort Laisuan, Wannada
collection PubMed
description Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.
format Online
Article
Text
id pubmed-8504472
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85044722021-10-20 CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes Laisuan, Wannada Wongsa, Chamard Chiewchalermsri, Chirawat Thongngarm, Torpong Rerkpattanapipat, Ticha Iamrahong, Pansa Ruangwattanachok, Chulapha Nanthapisal, Sira Sompornrattanaphan, Mongkhon J Asthma Allergy Case Series Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. Dove 2021-10-07 /pmc/articles/PMC8504472/ /pubmed/34675550 http://dx.doi.org/10.2147/JAA.S333098 Text en © 2021 Laisuan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Series
Laisuan, Wannada
Wongsa, Chamard
Chiewchalermsri, Chirawat
Thongngarm, Torpong
Rerkpattanapipat, Ticha
Iamrahong, Pansa
Ruangwattanachok, Chulapha
Nanthapisal, Sira
Sompornrattanaphan, Mongkhon
CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
title CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
title_full CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
title_fullStr CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
title_full_unstemmed CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
title_short CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
title_sort coronavac covid-19 vaccine-induced anaphylaxis: clinical characteristics and revaccination outcomes
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504472/
https://www.ncbi.nlm.nih.gov/pubmed/34675550
http://dx.doi.org/10.2147/JAA.S333098
work_keys_str_mv AT laisuanwannada coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT wongsachamard coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT chiewchalermsrichirawat coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT thongngarmtorpong coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT rerkpattanapipatticha coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT iamrahongpansa coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT ruangwattanachokchulapha coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT nanthapisalsira coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes
AT sompornrattanaphanmongkhon coronavaccovid19vaccineinducedanaphylaxisclinicalcharacteristicsandrevaccinationoutcomes

Ejemplares similares